Published in Nature on January 19, 1978
The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO J (2000) 2.17
DNA repair protein Rad55 is a terminal substrate of the DNA damage checkpoints. Mol Cell Biol (2000) 1.98
Phosphorylation of Rad55 on serines 2, 8, and 14 is required for efficient homologous recombination in the recovery of stalled replication forks. Mol Cell Biol (2006) 1.27
Error-free excision of the cytotoxic,mutagenic N2-deoxyguanosine DNA adduct formed in human fibroblasts by (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Proc Natl Acad Sci U S A (1980) 1.09
Cellular repair factors influencing radiocurability of human malignant tumours. Br J Cancer (1982) 1.00
Correlation among the rates of dimer excision, DNA repair replication, and recovery of human cells from potentially lethal damage induced by ultraviolet radiation. Biophys J (1979) 0.98
Effect of tumor promoters, protease inhibitors, and repair processes on x-ray-induced sister chromatid exchanges in mouse cells. Proc Natl Acad Sci U S A (1979) 0.98
Studies of cellular hypersensitivity to ionising radiation in Friedreich's ataxia. J Neurol Neurosurg Psychiatry (1982) 0.95
Studies on the radiosensitivity of cells from patients with basal cell naevus syndrome. Am J Hum Genet (1983) 0.95
Differential radiosensitivity phenotypes of DNA-PKcs mutations affecting NHEJ and HRR systems following irradiation with gamma-rays or very low fluences of alpha particles. PLoS One (2014) 0.79
MUC1-C Oncoprotein Interacts Directly with ATM and Promotes the DNA Damage Response to Ionizing Radiation. Genes Cancer (2010) 0.78
The influence of inhibitors of poly (ADP-ribose) polymerase on X-ray-induced potentially lethal damage repair. Br J Cancer Suppl (1984) 0.77
Deficient recovery from potentially lethal damage in some gamma-irradiated human fibroblast cell strains. Br J Cancer Suppl (1984) 0.77
Evolution of malignant plasmacytoma cell lines from K14E7 Fancd2-/- mouse long-term bone marrow cultures. Oncotarget (2016) 0.75
Head and neck cancer. N Engl J Med (1993) 6.33
Significance of the relationship between lung recoil and maximum expiratory flow. J Appl Physiol (1967) 5.87
Oligometastases. J Clin Oncol (1995) 4.95
Induction of sister chromatid exchanges by extremely low doses of alpha-particles. Cancer Res (1992) 4.72
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin. J Biol Chem (2000) 4.49
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res (1999) 4.17
Accurate three-dimensional registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr (1989) 3.12
Oncogenic point mutations in the human retinoblastoma gene: their application to genetic counseling. N Engl J Med (1989) 3.03
Intercellular communication is involved in the bystander regulation of gene expression in human cells exposed to very low fluences of alpha particles. Radiat Res (1998) 2.92
Direct evidence for the participation of gap junction-mediated intercellular communication in the transmission of damage signals from alpha -particle irradiated to nonirradiated cells. Proc Natl Acad Sci U S A (2001) 2.74
Unexpected sensitivity to the induction of mutations by very low doses of alpha-particle radiation: evidence for a bystander effect. Radiat Res (1999) 2.70
Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N Engl J Med (1992) 2.59
Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature (1995) 2.54
Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer. Int J Radiat Oncol Biol Phys (1995) 2.45
Xrcc3 is required for assembly of Rad51 complexes in vivo. J Biol Chem (1998) 2.44
Repair of potentially lethal radiation damage in vitro and in vivo. Radiology (1973) 2.43
Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest (1997) 2.42
Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature (1998) 2.29
Ku70: a candidate tumor suppressor gene for murine T cell lymphoma. Mol Cell (1998) 2.18
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol (2003) 2.09
Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells. Proc Natl Acad Sci U S A (1980) 2.08
Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res (2000) 2.06
Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci U S A (1989) 2.05
Plateau-phase cultures of mammalian cells: an in vitro model for human cancer. Curr Top Radiat Res Q (1972) 2.02
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol (1990) 1.90
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res (1993) 1.80
X-radiation-induced transformation in a C3H mouse embryo-derived cell line. Cancer Res (1976) 1.72
Lung cancer induced in hamsters by low doses of alpha radiation from polonium-210. Science (1975) 1.71
Mutation spectrum of the p53 gene in bone and soft tissue sarcomas. Cancer Res (1992) 1.60
Spatial and temporal control of gene therapy using ionizing radiation. Nat Med (1995) 1.59
Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. J Clin Oncol (1995) 1.59
Timing of the steps in transformation of C3H 10T 1/2 cells by X-irradiation. Nature (1984) 1.54
The bystander effect in radiation oncogenesis: II. A quantitative model. Radiat Res (2001) 1.52
Nasopharyngeal carcinoma. Lancet (1997) 1.51
The essential functions of human Rad51 are independent of ATP hydrolysis. Mol Cell Biol (1999) 1.51
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. Proc Natl Acad Sci U S A (1986) 1.51
Ionizing radiation regulates expression of the c-jun protooncogene. Proc Natl Acad Sci U S A (1990) 1.50
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res (1996) 1.44
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. J Clin Oncol (1994) 1.44
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am (1999) 1.42
X-ray sensitivity of fifty-three human diploid fibroblast cell strains from patients with characterized genetic disorders. Cancer Res (1980) 1.40
Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease. Int J Radiat Oncol Biol Phys (1995) 1.39
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. Cancer Invest (1995) 1.39
Potential role of WAF1/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J Biol Chem (1995) 1.38
Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys (1994) 1.38
Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN. Proc Natl Acad Sci U S A (1991) 1.36
The role of cdc2 in the expression of herpes simplex virus genes. Proc Natl Acad Sci U S A (2000) 1.34
Protease inhibitors suppress radiation-induced malignant transformation in vitro. Nature (1979) 1.33
Repair of sub-lethal and potentially lethal radiation damage in plateau phase cultures of human cells. Nature (1969) 1.33
Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo. Growth Factors (1996) 1.32
Somatic mutations at a heterozygous autosomal locus in human cells occur more frequently by allele loss than by intragenic structural alterations. Somat Cell Mol Genet (1986) 1.30
Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes. J Surg Oncol (1991) 1.29
Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumors. Gene Ther (1998) 1.26
Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc Natl Acad Sci U S A (1992) 1.25
Genetically engineered HSV in the treatment of glioma: a review. Rev Med Virol (2000) 1.24
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol (2000) 1.24
Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. Science (1989) 1.24
Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. J Clin Oncol (1997) 1.24
Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy. Cancer Res (1980) 1.22
Skin fibroblasts from a D-deletion type retinoblastoma patient are abnormally X-ray sensitive. Nature (1977) 1.21
Accumulation of specific RNAs encoding transcriptional factors and stress response proteins against a background of severe depletion of cellular RNAs in cells infected with herpes simplex virus 1. Proc Natl Acad Sci U S A (1999) 1.20
Deficient DNA repair in human progeroid cells. Proc Natl Acad Sci U S A (1973) 1.20
Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. Cancer Res (1992) 1.16
cdc2 cyclin-dependent kinase binds and phosphorylates herpes simplex virus 1 U(L)42 DNA synthesis processivity factor. J Virol (2001) 1.15
Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis. J Biol Chem (1997) 1.15
Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol (2001) 1.15
Mechanisms of human cell neoplastic transformation: X-ray-induced abnormal clone formation in long-term cultures of human diploid fibroblasts. Cancer Res (1985) 1.14
Increased ultraviolet sensitivity and chromosomal instability related to P53 function in the xeroderma pigmentosum variant. Cancer Res (1999) 1.14
Increased bystander mutagenic effect in DNA double-strand break repair-deficient mammalian cells. Int J Radiat Biol (2003) 1.13
Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. Cancer Res (1998) 1.13
Radiosensitivity in vitro of human soft tissue sarcoma cell lines and skin fibroblasts derived from the same patients. Int J Radiat Biol (1993) 1.13
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis. J Clin Oncol (1990) 1.12
The raf oncogene is associated with a radiation-resistant human laryngeal cancer. Science (1987) 1.12
Combined modality therapy of head and neck cancer. Semin Oncol (1994) 1.12
Loss of ceramide production confers resistance to radiation-induced apoptosis. Cancer Res (1997) 1.12
Enhancement of X-ray transformation by 12-O-tetradecanoyl-phorbol-13-acetate in a cloned line of C3H mouse embryo cells. Cancer Res (1978) 1.12
Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results. Int J Radiat Oncol Biol Phys (1995) 1.12
Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes. J Bone Miner Res (1994) 1.11
Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. J Natl Cancer Inst (1996) 1.11
Cell transformation by chemical agents--a review and analysis of the literature. A report of the U.S. Environmental Protection Agency Gene-Tox Program. Mutat Res (1983) 1.11
Persistently elevated frequency of spontaneous mutations in progeny of CHO clones surviving X-irradiation: association with delayed reproductive death phenotype. Mutat Res (1992) 1.11
Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1. Cell Growth Differ (1998) 1.11
Stress signaling from irradiated to non-irradiated cells. Curr Cancer Drug Targets (2004) 1.10
High and low fluences of alpha-particles induce a G1 checkpoint in human diploid fibroblasts. Cancer Res (2000) 1.10
Induction of oncogenic transformation in vitro by ultraviolet light. Nature (1976) 1.09
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors. Cancer Res (1999) 1.09
Posttranslational processing of infected cell proteins 0 and 4 of herpes simplex virus 1 is sequential and reflects the subcellular compartment in which the proteins localize. J Virol (2001) 1.09
Distribution of polonium-210 in pulmonary tissues of cigarette smokers. N Engl J Med (1965) 1.08
DNA crosslinking induced by x-rays and chemical agents. Biochim Biophys Acta (1977) 1.08
Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J Clin Invest (1991) 1.08
Release of spleen focus-forming virus (SFFV) from differentiation inducible promyelocytic leukemia cell lines transformed in vitro by Friend leukemia virus. Virology (1980) 1.08
X-ray sensitivity of human tumor cells in vitro. Int J Radiat Oncol Biol Phys (1980) 1.07
Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus. Clin Cancer Res (1999) 1.07